Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

594
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
594
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

748
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
748
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

614
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
614
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

404
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
404
Esophagus01:24

Esophagus

3.6K
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
3.6K
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

1.1K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gastric Adenocarcinoma Missed at the Incisura Angularis During Initial Endoscopy: A Case Report.

Clinical medicine insights. Case reports·2026
Same author

Emerging Role of Statin Therapy in Preventing Anthracycline-Induced Cardiotoxicity.

Cardiology research and practice·2026
Same author

Critical Airway Obstruction From a Near-Carinal Intratracheal Tumor Managed with Intratracheal Cryotherapy: A Case Report.

Clinical medicine insights. Case reports·2026
Same author

Beyond intestinal failure: Expanding therapeutic frontiers of glucagon-like peptide-2 in gastrointestinal disease.

World journal of gastrointestinal pharmacology and therapeutics·2026
Same author

The Great Imitator: A Case Report of Mirizzi Syndrome Misdiagnosed as Cholangiocarcinoma Bismuth Type II.

Clinical medicine insights. Case reports·2026
Same author

Air Everywhere: A Rare Post-ERCP Syndrome of Acute Pancreatitis, Pneumothorax, and Multicompartment Air Leak without Perforation.

Clinical medicine insights. Case reports·2026

Related Experiment Video

Updated: Jan 11, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.4K

Barrett's Esophagus.

Antonio Al Hazzouri1, Philippe Attieh1, Tony Azizi1

  • 1Department of Biomedical Sciences, Faculty of Medicine and Medical Sciences, University of Balamand, Beirut, Lebanon.

Journal of Gastroenterology and Hepatology
|November 13, 2025
PubMed
Summary
This summary is machine-generated.

Barrett's esophagus (BE) is a precancerous condition that increases esophageal adenocarcinoma risk. This review covers BE pathophysiology, diagnosis, management, and emerging innovations for better patient outcomes.

Keywords:
Barrett's esophagusendoscopic surveillanceesophageal adenocarcinomagastroesophageal reflux diseaserisk stratification

More Related Videos

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.4K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

747

Related Experiment Videos

Last Updated: Jan 11, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.4K
Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.4K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

747

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Barrett's esophagus (BE) involves esophageal metaplasia, increasing esophageal adenocarcinoma (EAC) risk.
  • Chronic gastroesophageal reflux disease (GERD) is a primary driver of BE development.
  • EAC incidence is rising, particularly in Western countries.

Purpose of the Study:

  • To provide a comprehensive review of current understanding and management of BE.
  • To examine BE pathophysiology, risk factors, and diagnostic approaches.
  • To compare international guidelines and explore emerging innovations for BE treatment and surveillance.

Main Methods:

  • Review of major international guidelines (AGA, ESGE, BSG) and recent advancements.
  • Analysis of underlying pathophysiology, molecular alterations, and risk factors.
  • Evaluation of diagnostic protocols, including endoscopy, histology, and advanced imaging.

Main Results:

  • BE management involves medical, endoscopic, and surgical strategies, with varying guideline recommendations.
  • Effective surveillance is crucial but faces adherence barriers.
  • Emerging innovations include AI-imaging, novel biopsies, and personalized medicine.

Conclusions:

  • Personalized, guideline-adherent care is essential for optimizing outcomes in BE patients.
  • Improved early diagnosis and risk stratification are critical for reducing EAC progression.
  • Integrating current evidence and technological advances will enhance BE patient management.